Archive for the 'Acomplia' Category
Acomplia linked to 5 deaths in the UK
Posted on June 22, 2008 - Filed Under Acomplia | Leave a Comment
Five lives have been claimed and 720 adverse drug reactions have occurred in Britain since the launch of France’s Sanofi-Aventis SA’s weight-loss drug, Acomplia, two years ago; this, according to a posting on the United Kingdom’s drug regulator’s Website this week. Acomplia—known generically as rimonabant—had been slated to be a multi-billion dollar seller; however, following [...]
Acomplia 2007 Overall Results
Posted on May 21, 2008 - Filed Under Acomplia | Leave a Comment
Acomplia (generic name rimonabant) has been an authorised medication in the EU since June 2006 for use in adult patients where the BMI exceeds 30 or the BMI exceeds 27 with associated risk factors such as diabetes. In all cases it can only be prescribed in conjunction with a hypocaloric diet and physical exercise.
In March [...]
Obesity Drugs for Kids
Posted on May 9, 2008 - Filed Under Acomplia, Weight Loss | Leave a Comment
A new class of weight loss pills that suppress appetite through receptors in the brain could affect on visual perseption in children.
The appetite suppressing receptors are called cannabinoid receptors. They control the plasticity and also regulate signaling among neurons in the visual cortex.
The researchers looked at the drug rimonabant (Acomplia). Findings suggest obesity drugs that [...]
Weight Loss Medication Acomplia Rimonabant
Posted on April 1, 2008 - Filed Under Acomplia | Leave a Comment
Acomplia is an oral prescription medication which has created waves in the weight loss market ever since its launch in the UK. Subsequent to which it has been launched in various other countries such as France, Germany, Ireland, Austria, Argentina, Denmark, Holland and Sweden. Some of the prospective countries which can witness the launch of [...]
Acomplia - Lose weight, ease illness, quit smoking.
Posted on January 1, 2007 - Filed Under Acomplia | Leave a Comment
Sanofi-Aventis SA’s new treatment, Acomplia, also known as rimonabant, has shown promise in a half-dozen clinical trials in curbing the cravings that make people hungry and reach for a cigarette.
The experimental drug, which works differently from other weight-loss medicines, could be approved by the Food and Drug Administration as soon as this month. And industry [...]
